Singapore, Feb. 20, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global Lymphedema Treatment Market was estimated at US$ 780 million in 2021 and is expected to surpass a valuation of US$ 1,572 million by 2030, progressing at a CAGR of 8.1% from 2022 to 2030. The report provides a detailed analysis of top winning strategies, drivers & opportunities, competitive scenario, wavering market trends, market size, statistics & estimations, and major investment pockets. The rapidly increasing adoption of digitalization due to growing urbanization is a major driver for the Lymphedema Treatment Market.
Get a Sample PDF Brochure:
https://www.growthplusreports.com/inquiry/request-sample/lymphedema-treatment-market/8253
Market Drivers
The prevalence of lymphedema is rising globally as a result of a rising geriatric population, increasing cancer cases, and a surge in surgical procedures. Since these factors can all raise the risk of lymphedema, there is an increased demand for associated treatments. Significant improvements have been made in the development of new surgical techniques, compression garments, and cutting-edge medicines, including stem cell and gene therapy. These novel therapeutic approaches will likely improve treatment outcomes and broaden the treatment options. Governments all across the world are taking steps to spread knowledge about lymphedema and give the patients better treatment options. For instance, the Lymphedema Therapy Act of 2022 (U.S.) was developed to enhance access to lymphedema treatment. Such events are fueling the market for lymphedema treatments. Additionally, the expanding accessibility of lymphedema supplies and accessories is anticipated to boost the growth of the lymphedema treatment market. Patients now have better access to lymphedema treatment alternatives due to rising healthcare costs worldwide. This is anticipated to fuel the market for lymphedema treatment to rise in the upcoming years.
The global lymphedema treatment market is analyzed from three perspectives: Indication, Treatment Type, End-user, and Region.
Excerpts from ‘By Indication Segmentation’
Based on the indications, the global lymphedema treatment market is segmented into:
- Primary Lymphedema
- Secondary Lymphedema
With the highest revenue share in 2021, the secondary lymphedema segment dominated the global lymphedema treatment market. Compared to primary lymphedema, secondary lymphedema has a higher occurrence rate since it can affect people of all ages and be brought on by a variety of causes. As a result, the number of patients needing therapy increases, promoting segment growth. Patients are more likely to seek treatment for secondary lymphedema due to increased awareness of the possibility of developing lymphedema following cancer therapy or surgery. The market is growing as a result of the availability of more treatment options for secondary lymphedema, such as compression therapy, manual lymphatic drainage, and surgery. Treatment for secondary lymphedema may be covered by reimbursement rules in some nations, making it more accessible to patients. This can increase the need for lymphedema therapies, thus fueling the segment growth.
Excerpts from ‘By Treatment Type Segmentation’
Based on the treatment type, the global lymphedema treatment market is segmented into:
- Compression Therapy
- Drug Therapy
- Laser Therapy
In 2021, compression therapy had the highest revenue share of the lymphedema treatment market. Compression therapy has been proven useful in lowering swelling and enhancing lymphatic flow. Compression therapy is increasingly needed in the management of lymphedema since it is frequently advised as the first-line therapy for the ailment and is regarded as a standard of care. Compression therapy is a non-invasive procedure that does not involve surgery or drugs. Because of this, it is a desirable alternative for individuals who choose non-invasive therapies or cannot have surgery. Compression therapy is widely available and can be easily applied by patients or by healthcare professionals. Compression garments come in a variety of sizes and styles, and they can be worn during normal daily activities, which is expected to increase the demand for compression therapy.
Excerpts from ‘By Region Segmentation’
Geographically, the global lymphedema treatment market has been segmented into:
- North America
- Europe
- Asia Pacific
- The Rest Of The World
In 2021, North America dominated the market for lymphedema treatments worldwide. The relatively high prevalence of lymphedema in North America generates the need for therapeutic solutions. As stated in lymphedematreatmentact.org, around 3 to 5 million people are suffering from lymphedema. In North America, interest in novel and cutting-edge lymphedema therapies has increased. Such therapies include:
- Liposuction
- pneumatic compression devices
- lymphaticovenous anastomosis (LVA)
Some of the world's most cutting-edge medical technologies, including tools and techniques for surgery that can be utilized to treat lymphedema, are found in North America. It has sparked the creation of cutting-edge lymphedema treatment solutions in the region. The healthcare system in North America has well-established reimbursement policies for lymphedema treatment, which makes it more accessible and affordable for patients. There is a growing emphasis on patient-centered care in the North American lymphedema treatment market, with healthcare providers focusing on individualized treatment plans that consider each patient's unique needs and circumstances, thus boosting the regional market growth.
Excerpts from ‘Competitive Landscape’
Some prominent players operating in the global lymphedema treatment market are:
- Bio Compression Systems Inc.
- Airos Medical Inc.
- Tactile Systems Technology Inc
- Smith & Nephew Plc
- Bsn Medical Gmbh
- Cardinal Health Inc.
- Lohmann & Rauscher Gmbh & Co. Kg
- 3m Company
- Wright Therapy Products
- Mego Afek Ltd.
- Herantis Pharma Plc
- Sigvaris Group
Inquire Before Buying This Research Report:
https://www.growthplusreports.com/inquiry/before-buying/lymphedema-treatment-market/8253
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecast Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL LYMPHEDEMA TREATMENT MARKET - ANALYSIS & FORECAST, BY INDICATION
- Primary Lymphedema
- Secondary Lymphedema
- GLOBAL LYMPHEDEMA TREATMENT MARKET - ANALYSIS & FORECAST, BY TREATMENT TYPE
- Compression Therapy
- Drug Therapy
- Laser Therapy
- Others
TOC Continued…
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
